# Oliceridine in Patients With Acute Burn Injuries

> **NCT05465226** · PHASE4 · COMPLETED · sponsor: **University of Tennessee** · enrollment: 31 (actual)

## Conditions studied

- Acute Pain
- Burns
- Adverse Drug Event
- Respiratory Depression
- Nausea and Vomiting, Postoperative

## Interventions

- **DRUG:** Oliceridine
- **DRUG:** Historical opioid use

## Key facts

- **NCT ID:** NCT05465226
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-10-24
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05465226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05465226, "Oliceridine in Patients With Acute Burn Injuries". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05465226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*